Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
enolase 1 | 0.481 | 0.885 | 1.9E-05 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2005 | 2017 | ||||||||
|
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 | 0.559 | 0.654 | 6.7E-08 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 6 | 0.582 | 0.692 | 2.7E-09 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2004 | 2007 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2020 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
collagen type I alpha 2 chain | 0.486 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2009 | ||||||||
|
cathepsin D | 0.478 | 0.846 | 9.2E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1995 | 2009 | ||||||||
|
aldo-keto reductase family 1 member C1 | 0.593 | 0.615 | 3.5E-15 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
tripartite motif containing 2 | 0.686 | 0.538 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
glutathione S-transferase kappa 1 | 0.412 | 0.885 | 1.9E-06 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2018 | ||||||||
|
latent transforming growth factor beta binding protein 3 | 0.564 | 0.846 | 0.69 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
bone morphogenetic protein 6 | 0.531 | 0.808 | 0.76 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2018 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
matrix metallopeptidase 13 | 0.452 | 0.923 | 7.9E-18 |
|
disease | 0.200 | None | 0.983 | 172 | 0 | 1996 | 2020 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 105 | 0 | 1996 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.200 | None | 0.900 | 9 | 1 | 1998 | 2018 | ||||||||
|
solute carrier family 39 member 8 | 0.584 | 0.769 | 0.67 |
|
disease | 0.160 | None | 1.000 | 6 | 0 | 2013 | 2019 | ||||||||
|
DOT1 like histone lysine methyltransferase | 0.599 | 0.692 | 1.00 |
|
disease | 0.160 | None | 1.000 | 6 | 1 | 2012 | 2019 | ||||||||
|
collagen type XI alpha 1 chain | 0.495 | 0.846 | 1.00 |
|
disease | 0.150 | None | 1.000 | 5 | 3 | 2013 | 2019 | ||||||||
|
collagen type XI alpha 2 chain | 0.435 | 0.846 | 0.70 |
|
disease | 0.150 | None | 1.000 | 5 | 0 | 2005 | 2019 | ||||||||
|
ANKH inorganic pyrophosphate transport regulator | 0.606 | 0.692 | 0.28 |
|
disease | 0.150 | None | 1.000 | 5 | 0 | 2004 | 2016 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.140 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
collagen type IX alpha 1 chain | 0.566 | 0.731 | 3.1E-19 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 2000 | 2014 |